Journal
EMERGING INFECTIOUS DISEASES
Volume 26, Issue 11, Pages 2769-2770Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2611.203283
Keywords
-
Categories
Funding
- Department for International Development/Wellcome Trust [220764/Z/20/Z]
- Pfizer [WI255862]
- National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections
- Centre of Excellence in Infectious Diseases Research
- Alder Hey Charity
- Liverpool Health Partners
- Liverpool Malawi COVID-19 consortium
- Wellcome Trust [220764/Z/20/Z] Funding Source: Wellcome Trust
Ask authors/readers for more resources
PCR of upper respiratory specimens is the diagnostic standard for severe acute respiratory syndrome coronavirus 2 infection. However, saliva sampling is an easy alternative to nasal and throat swabbing. We found similar viral loads in saliva samples and in nasal and throat swab samples from 110 patients with coronavirus disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
